rs3917980

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000760.4(CSF3R):​c.1254T>C​(p.Arg418Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.329 in 1,613,654 control chromosomes in the GnomAD database, including 90,674 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 6838 hom., cov: 33)
Exomes 𝑓: 0.33 ( 83836 hom. )

Consequence

CSF3R
NM_000760.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.68

Publications

22 publications found
Variant links:
Genes affected
CSF3R (HGNC:2439): (colony stimulating factor 3 receptor) The protein encoded by this gene is the receptor for colony stimulating factor 3, a cytokine that controls the production, differentiation, and function of granulocytes. The encoded protein, which is a member of the family of cytokine receptors, may also function in some cell surface adhesion or recognition processes. Alternatively spliced transcript variants have been described. Mutations in this gene are a cause of Kostmann syndrome, also known as severe congenital neutropenia. [provided by RefSeq, Aug 2010]
CSF3R Gene-Disease associations (from GenCC):
  • hereditary neutrophilia
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • autosomal recessive severe congenital neutropenia due to CSF3R deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.008).
BP6
Variant 1-36471464-A-G is Benign according to our data. Variant chr1-36471464-A-G is described in ClinVar as Benign. ClinVar VariationId is 256789.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.68 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.382 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CSF3RNM_000760.4 linkc.1254T>C p.Arg418Arg synonymous_variant Exon 10 of 17 ENST00000373106.6 NP_000751.1 Q99062-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CSF3RENST00000373106.6 linkc.1254T>C p.Arg418Arg synonymous_variant Exon 10 of 17 1 NM_000760.4 ENSP00000362198.2 Q99062-1

Frequencies

GnomAD3 genomes
AF:
0.289
AC:
43964
AN:
151966
Hom.:
6844
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.197
Gnomad AMI
AF:
0.578
Gnomad AMR
AF:
0.268
Gnomad ASJ
AF:
0.371
Gnomad EAS
AF:
0.116
Gnomad SAS
AF:
0.397
Gnomad FIN
AF:
0.338
Gnomad MID
AF:
0.405
Gnomad NFE
AF:
0.340
Gnomad OTH
AF:
0.288
GnomAD2 exomes
AF:
0.313
AC:
78552
AN:
251318
AF XY:
0.324
show subpopulations
Gnomad AFR exome
AF:
0.196
Gnomad AMR exome
AF:
0.256
Gnomad ASJ exome
AF:
0.355
Gnomad EAS exome
AF:
0.101
Gnomad FIN exome
AF:
0.343
Gnomad NFE exome
AF:
0.345
Gnomad OTH exome
AF:
0.325
GnomAD4 exome
AF:
0.333
AC:
487263
AN:
1461568
Hom.:
83836
Cov.:
46
AF XY:
0.336
AC XY:
244659
AN XY:
727088
show subpopulations
African (AFR)
AF:
0.189
AC:
6335
AN:
33476
American (AMR)
AF:
0.255
AC:
11399
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.364
AC:
9510
AN:
26136
East Asian (EAS)
AF:
0.0837
AC:
3321
AN:
39698
South Asian (SAS)
AF:
0.407
AC:
35089
AN:
86250
European-Finnish (FIN)
AF:
0.345
AC:
18415
AN:
53414
Middle Eastern (MID)
AF:
0.355
AC:
2044
AN:
5754
European-Non Finnish (NFE)
AF:
0.344
AC:
382139
AN:
1111740
Other (OTH)
AF:
0.315
AC:
19011
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
18869
37738
56607
75476
94345
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12168
24336
36504
48672
60840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.289
AC:
43949
AN:
152086
Hom.:
6838
Cov.:
33
AF XY:
0.288
AC XY:
21420
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.197
AC:
8179
AN:
41524
American (AMR)
AF:
0.268
AC:
4094
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.371
AC:
1285
AN:
3468
East Asian (EAS)
AF:
0.115
AC:
596
AN:
5164
South Asian (SAS)
AF:
0.396
AC:
1912
AN:
4824
European-Finnish (FIN)
AF:
0.338
AC:
3575
AN:
10570
Middle Eastern (MID)
AF:
0.401
AC:
118
AN:
294
European-Non Finnish (NFE)
AF:
0.339
AC:
23064
AN:
67936
Other (OTH)
AF:
0.285
AC:
601
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1627
3254
4880
6507
8134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
462
924
1386
1848
2310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.324
Hom.:
12907
Bravo
AF:
0.277
Asia WGS
AF:
0.229
AC:
799
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive severe congenital neutropenia due to CSF3R deficiency Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 22, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.13
DANN
Benign
0.53
PhyloP100
-2.7
PromoterAI
-0.0031
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3917980; hg19: chr1-36937065; COSMIC: COSV58963449; COSMIC: COSV58963449; API